Ingestible Sensors - Global Strategic Business Report

Global Ingestible Sensors Market to Reach $2.9 Billion by 2030

The global market for Ingestible Sensors estimated at US$1 Billion in the year 2022, is projected to reach a revised size of US$2.9 Billion by 2030, growing at a CAGR of 14% over the analysis period 2022-2030. Temperature, one of the segments analyzed in the report, is projected to record 13.4% CAGR and reach US$1.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Pressure segment is readjusted to a revised 13.7% CAGR for the next 8-year period.

The U.S. Market is Estimated at $266 Million, While China is Forecast to Grow at 18% CAGR

The Ingestible Sensors market in the U.S. is estimated at US$266 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$683.5 Million by the year 2030 trailing a CAGR of 18% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.5% and 12.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 11.7% CAGR.

Select Competitors (Total 42 Featured) -

• Capsovision, Inc.
• Hq, Inc.
• Mc10, Inc.
• Microchips Biotech, Inc.
• Olympus Corporation
• Proteus Digital Health, Inc.

What's New?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year